Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula
ALFoNS - Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula Compared to Breastfed Infants
Sponsor: Arla Foods
A NA clinical study on Growth and Infection, this trial is ongoing. The trial is conducted by Arla Foods and has accumulated 12 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Jan 2025 — Sep 2025 [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: PHASE1 → NA
▶ Show 7 earlier versions
-
Jan 2021 — Sep 2022 [monthly]
Recruiting PHASE1
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE1
Status: Unknown Status → Recruiting · Phase: PHASE1_PHASE2 → PHASE1
-
Jan 2019 — Jan 2020 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Arla Foods
- Skane University Hospital
- Umeå University
- University of California, Davis
For direct contact, visit the study record on ClinicalTrials.gov .